by Vora Corporate Finance | Jan 4, 2025 | Insights
There were 15 main board IPOs in December 2024 of Suraksha Diagnostics Limited, as One Mobikwik Systems Limited, Sai Life Sciences Limited, Vishal Mega Mart Limited, Inventurus Knowledge Solutions LIMITED, International Gemmolgical Institue India Limited, Transrail...
by Vora Corporate Finance | Dec 20, 2024 | Insights, Merger & Acquisitions
Transaction: Metropolis Healthcare Limited, India’s second-largest pathology chain acquires 100% stake in oncology-focused diagnostic services provider Core Diagnostics for Rs 246.8 Crore. The acquisition will take place through a combination of cash and stock, with...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
Transaction: Beta Drugs, a vertically integrated cancer firm, raised INR 117 crore in a funding round led by HealthQuadFund II, Inti Capital and Generational Capital for a minority stake in the company. The stake has been given through preferential allotment of...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Merger & Acquisitions
Transaction: Ahead of the merger, Aster will purchase a 5.0% stake in Quality Care from Blackstone and TPG in consideration of primary share issuance by Aster for a 3.6% stake. Post the initial share acquisition, Quality Care will be merged into Aster by way of a...
by Vora Corporate Finance | Dec 16, 2024 | Insights, Private Equity & IPO
There were 08 main board IPOs in November 2024 of Afcons Infrastructure Limited, Sagility India Limited, Swiggy Limited, ACME Solar Holdings Limited, Niva Bupa Health Insurance Limited, Zinka Logistics Solutions Limited, NTPC Green Energy Limited and Enviro Infra...
